Output Explorer

Every prompt in the paper, and what each model wrote back.

Answer a question about a scanned page from its OCR text. Scored by exact match and ANLS against the accepted answers.

13 of 5,330 prompts

Nearby prompts. All 5,330 DocVQA prompts

PromptDocVQA · pagergcw0217_2.png

Who is the Director, Scientific Publications, US Medical Research at Aventis?

OCR text of the page · 4,443 characters; the scanned image itself is not published
To promote the understanding of efficient and scientifically rigorous publication planning processes as a core component
of the dinical development and commercialization processes within biopharmaceuticals.
Dear Colleague:
Publication Planning is the process of creating timely and targeted disseminations of new scientific and clinical data
throughout the life cycle of a product. In past years, the Pharmaceutical and Biotechnology Industries have paid minimal
attention to this essential process and this can no longer be the case. The lengthy clinical development and regulatory review
cycles increase the urgency to maximize a brand's contribution at launch. Therefore, a well-conceived and executed publication
plan must be in place from early in a product's development and maintained throughout its lifecycle. The drive to maximize
efficiencies and minimize waste affects all involved in the process, including the Industry, Academia and service providers.
For a manufacturer, having research published in a highly regarded peer-review medical journal or presented at a leading
conference is desirable. It demonstrates to the audience the validity of the data presented in these selective vehicles and adds
credibility to its subsequent use in educational or promotional initiatives. Ultimately this stream of credible publications and
presentations help to create awareness of the emerging clinical profile of a product, and to establish its place in practice.
Therefore, a strong publications strategy becomes an excellent platform to jump-start a strong marketing plan, which can be
ranslated into both educational and promotional activities. The key is to know where to begin and how to calculate the most
beneficial publications program for your product to ensure optimal exposure.
Pharmaceutical Education Associates is proud to present Publication Planning 2003: Utilizing Scientifically Accurate,
Commercially Relevant Strategies for Optimal Drug Acceptance and Exposure, the only conference of its kind. Hear from top
global experts from Aventis, AstraZeneca, Wyeth, EMD, Takeda, Amgen, Biogen, PeerView, Astrolabe Analytica, Current
Medical Research and Opinion, Medscape General Medicine, ( the Matalia Group, KV Medical Directions,
and Covington & Burling on topics including:
Why we publish scientific studies and articles
Identifying the roles of clinical development and commercial team members within a publication program
Establishing a scientifically rigorous and commercially relevant evidence base
Obtaining maximum impact of a publication strategy through clinically relevant data mining
Selecting optimal venues to reach your target audience
Utilizing the solid foundation of peer reviewed publications to support all elements of the marketing mix
How vendors can contribute to the overall success of a publication program
...and much more!
Don't miss the Post Conference Tutorial, Publication Partnerships: How to Select and Manage Your Medical Communications
Agency facilitated by Richard F. Lamb, Director, Scientific Publications, US Medical Research at Aventis and Timothy D. Bacon,
President & CEO of PeerView, Inc. Mr. Lamb and Mr. Bacon lead you through a highly-interactive session geared to teach you
how to best select a vendor partner to both complement and assist with facilitating your company's publication plan.
Register early and reserve your spot! Call us at 800-686-2276 or register online at www.pharmedassociates.com. To fax your
registration, complete the form on the last page of this brochure and fax it to 360-666-3549. Join us on November 12, 2003 in
Princeton, NJ for this exciting event!
Sincerely
Kimberly J:"Goldin, Conference Producer
PHARMACEUTICAL EDUCATION ASSOCIATES
Who Should Attend
Publication Planning 2003: Utilizing Scientifically Accurate, Commercially
Relevant Strategies for Optimal Drug Acceptance and Exposure
responsibilities in:
This conference is designed for senior level management within the Pharmaceutical and Biotechnology Industries with
Publications
* Marketing
Clinical Publications
Continuing Medical
. Publication Planning
. Brand/Product
Medical/Biomedical
Education (CME)
. Medical Affairs
Development
Communications
Clinical Development
. Medical Writers
This conference is also of interest to:
Medical Pharmaceutical Public Relations and Advertising Firms . Medical Education Agencies
Medical Communications Firms
. Publication Software Manufacturers
System prompt · identical for every setup
Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.
Expected answer
Richard F. Lamb
Models
4 of 4 columns · click a model to add or remove it

Ours

Exact match

Richard F. Lamb

15 characters5 tokens

Aux 2015

Wrong

To promote the understanding of efficient and scientifically rigorous publication planning processes as a core component of the dinical development and commercialization processes within biopharmaceuticals.

206 characters33 tokens

PiT-FT 2015

Wrong

<|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|> <|>

64 characters64 tokens

ChronoGPT 2015

Wrong

Publication Planning 2003: Utilizing Scientifically Accurate, Commercially Relevant Strategies for Optimal Drug Acceptance and Exposure

Keywords:

Publication Planning, Scientific Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications, Publications

364 characters64 tokens